Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease

被引:0
|
作者
Sykora, Daniel [1 ]
Firth, Christine [2 ]
Girardo, Marlene [3 ]
Tseng, Andrew [4 ]
Wennberg, Paul [5 ]
Liedl, David [5 ]
Shamoun, Fadi [2 ]
机构
[1] Mayo Clin, Sch Grad Med Educ, Rochester, MN USA
[2] Mayo Clin, Dept Cardiovasc Dis, Phoenix, AZ USA
[3] Mayo Clin, Div Hlth Sci Res, Dept Biomed Stat & Informat, Scottsdale, AZ USA
[4] Mayo Clin, Dept Cardiovasc Dis, Jacksonville, FL USA
[5] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
关键词
Peripheral artery disease (PAD); lower extremity artery disease; diabetes mellitus; limb ischemia; type; 1; diabetes; 2; MORTALITY; ASSOCIATION; PREVALENCE; MANAGEMENT;
D O I
10.1024/0301-1526/a001086
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Peripheral artery disease (PAD) is a risk factor for adverse limb events (LE) and cardiovascular events (CVE) that coexists with type 1 (T1) and 2 (T2) diabetes mellitus (DM). Little is known about comparative risk of LE and CVE in T1/T2 DM patients with PAD. Patients and methods: We queried our database of 40,144 patients >= 18 years old who underwent ankle brachial index (ABI) measurement from 01/1996-02/2020. We isolated T1/T2 DM patients with PAD diagnosed by ankle brachial index (ABI; low [<1.0] or elevated [>1.4]) and retrieved demographics including glycated hemoglobin (HbA1c). Primary outcomes were LE (critical limb ischemia/vascular amputation) and CVE (myocardial infarction/ ischemic stroke). All-cause mortality was a secondary outcome. Multivariable Cox proportional regression yielded hazard ratios (HR) with 95% confidence intervals (CI) after adjusting for pertinent risk factors including age, hypertension, hyperlipidemia, smoking, and HbA1c. Results: Our study found 10,156 patients with PAD and DM (34% T1DM, 66% T2DM) with median follow-up time 34 mo (IQR 85 mo). T1DM patients were younger than T2DM (mean age 67 vs. 70 years), with higher median HbA1c (7.7 [IQR 1.9] vs. 6.7% [IQR 1.6]), and more prevalent hypertension, hyperlipidemia, CAD, and CKD. Antiplatelet and statin use was equivocal. Elevated ABI was more common in T1DM (47 vs. 28%). LE occurred in 23% and CVE in 12% patients. LE risk was higher in T1 than T2 DM patients (HR 1.58 [95% CI 1.44, 1.73], p<0.0001), but CVE and all-cause mortality were equivocal. These observations were preserved across ABI and HbA1c subgroup analyses. Conclusions: PAD patients with T1DM had a higher LE risk than those with T2DM, even after adjustment for glycemic control and pertinent risk factors, but CVE risk and all-cause mortality were equivocal. These data suggest a potential role for more intensive LE risk modification in PAD patients with T1DM, but further investigation is needed.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 50 条
  • [31] Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease
    Tsujimoto, Tetsuro
    Kajio, Hiroshi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 282 : 1 - 6
  • [32] Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk
    Colom, Cristina
    Rull, Anna
    Sanchez-Quesada, Jose Luis
    Perez, Antonio
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [33] RISK MARKERS FOR CARDIOVASCULAR DISEASE IN YOUNG TYPE 1 DIABETIC PATIENTS: LIPOPROTEINS, HIGH-SENSITIVITY C-REACTIVE PROTEIN AND ADIPONECTIN
    Messaaoui, A.
    Willems, D.
    Melot, C.
    Dorchy, H.
    ACTA CLINICA BELGICA, 2012, 67 (02) : 79 - 82
  • [34] Limb Perfusion Imaging in Peripheral Artery Disease
    Lindner, Jonathan R.
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (08) : 1625 - 1627
  • [35] Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes
    Dei Cas, Alessandra
    Aldigeri, Raffaella
    Mantovani, Alessandro
    Masulli, Maria
    Palmisano, Luisa
    Cavalot, Franco
    Bonomo, Katia
    Baroni, Marco Giorgio
    Cossu, Efisio
    Cavallo, Gisella
    Cimini, Flavia Agata
    Buzzetti, Raffaella
    Mignogna, Carmen
    Leonetti, Frida
    Bacci, Simonetta
    Trevisan, Roberto
    Morieri, Mario Luca
    Pollis, Riccardo Maria
    Targher, Giovanni
    de Kreutzenberg, Saula Vigili
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (09) : E789 - E798
  • [36] Attainment of LDL-cholesterol target in high cardiovascular risk type 1 diabetic French people
    Breuker, Cyril
    Macioce, Valerie
    Lasse, Alexandre
    Zogheib, Marie-Lou
    Cavallin, Leslie
    Herman, Fanchon
    Picot, Marie-Christine
    Gourdy, Pierre
    Sallerin, Brigitte
    Avignon, Antoine
    Sultan, Ariane
    DIABETES & METABOLISM, 2024, 50 (06)
  • [37] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Htay, Thwe
    Soe, Kyaw
    Lopez-Perez, Arianna
    Amy HoangAnh Doan
    Romagosa, Michael A.
    Aung, KoKo
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (06)
  • [38] Fibroblast growth factor 23 serum level in type 2 diabetic italian subjects with peripheral arterial disease and critical limb ischemia
    Biscetti, F.
    Straface, G.
    Pitocco, D.
    Angelini, F.
    Tinelli, G.
    Landolfi, R.
    Flex, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (19) : 4048 - 4054
  • [39] Study of cardiovascular risk factors in Tunisian patients with recent type 2 diabetes
    Bouzid, K.
    Ben Miled, F. Ben Mami
    Hassine, M.
    Kalai, E.
    Ben Ahmed, H.
    Boujnah, R.
    Achour, A.
    Bahlous, A.
    Abdelmoula, J.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2012, 61 (02): : 81 - 87
  • [40] Peripheral Arterial Stiffness Increases the Risk of Progression of Renal Disease in Type 2 Diabetic Patients
    Lim, Tae Hoon
    Chung, Seung Min
    Lee, Dong Sung
    Choi, Se Ra
    Moon, Jun Sung
    Yoon, Ji Sung
    Won, Kyu Chang
    Lee, Hyoung Woo
    FRONTIERS IN MEDICINE, 2020, 7